首页> European journal of clinical pharmacology> Efficacy and safety of CGRP monoclonal antibodies for migraine prevention in episodic migraine; a network Meta-analysis.

Efficacy and safety of CGRP monoclonal antibodies for migraine prevention in episodic migraine; a network Meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ishwa,Shakir

第一单位： College of Medicine, Islamic International Medical College, Rawalpindi, Pakistan.

作者： Ishwa,Shakir ^[1] ; Faizan,Shahzad ^[2] ; Ahsan,Shabbir ^[3] ; Saba,Shahabuddin ^[4] ; Haroon,Shabbir ^[1] ; Sobia,Karamat ^[5] ; Saad,Hulou ^[6] ; Abdul Rauf,Khalid ^[7] ; Syed Ijlal,Ahmed ^[8]

作者单位： College of Medicine, Islamic International Medical College, Rawalpindi, Pakistan. ^[1] College of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. ^[2] College of Medicine, United Medical and Dental College, Karachi, Pakistan. ^[3] College of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan. ^[4] Department of Ophthalmology, Amir Eye Hospital, Rawalpindi, Pakistan. ^[5] College of Medicine, University of Aleppo, Aleppo, Syria. Saad.Hulou98@gmail.com.;Department of Neurosurgery, University of kentucky, Lexington, KY, USA. Saad.Hulou98@gmail.com. ^[6] College of Medicine, Bahria International Hospital Orchard, Lahore, Pakistan. ^[7] Department of Neurology, Saint Louis University School of Medicine, St. Louis, MO, USA. ^[8]

关键词 CGRP monoclonal antibodies Galcanezumab Migraine preventionSafety and efficacy Erenumab Fremanezumab Migraine Network meta-analysis

医学主题词人类(Humans);抗体, 单克隆(Antibodies, Monoclonal);降钙素基因相关肽(Calcitonin Gene-Related Peptide);偏头痛(Migraine Disorders);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1007/s00228-025-03934-3

PMID 41546694

发布时间 2026-02-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交